Diabetic Kidney Disease: Improving Outcomes and Reducing Costs

Activity description
Diabetes is the leading cause of kidney failure and accounts for 44% of new cases, while more than 35% of diabetic individuals aged 20 or older have chronic kidney disease (CKD). It is imperative that health care providers (HCPs) initiate treatment early in this population to prevent kidney damage and delay progression to end-stage renal disease (ESRD) and avoid concomitant cardiovascular disease (CVD), which is often associated with these conditions. This activity will present HCPs with the information necessary to evaluate kidney health in individuals with type 2 diabetes mellitus (T2DM) and will discuss CKD risk stratification, including interpretation of albuminuria levels and estimated glomerular filtration rate (eGFR). Interventions that can reduce progression of disease, likelihood of hospitalization and costs will be identified, and recent data about effective treatment regimens and their indications for improving outcomes will be examined. Additionally, early strategies to decrease the risk for CVD and ESRD in these individuals will be defined, with a review of the pathophysiology of progression of these disorders. 

Provided by
This activity is provided by OptumHealth Education and OptumLabs.

Commercial support
No commercial support was received for this activity.
Required hardware/software
Please ensure you are using the web-browser Chrome and disable any pop-up blocking software. Click here for information on how to enable pop-ups.

Target Audience

This activity is designed to meet the educational needs of nurses, nurse practitioners, PAs, physicians, psychologists, social workers and other HCPs who have an interest in diabetic kidney disease.

Learning Objectives

At the end of this educational activity, participants should be able to:

  • Define applications of eGFR and urine albumin-creatinine ration (uACR) tests in individuals with T2DM for detection and risk stratification of CKD as defined by the kidney health evaluation for patients with diabetes Healthcare Effectiveness Data and Information Set (HEDIS) measure
  • Describe how CKD risk stratification informs interventions to reduce kidney failure, decrease cardiovascular risk and limit hospitalizations
  • Cite recent studies of the kidney and cardiovascular protective effects of specific treatment regimens, and their indications for management in individuals with T2DM and CKD
  • Examine interventions to decrease the risks for cardiovascular disease and dialysis in individuals with T2DM and CKD, based on an understanding of the pathophysiology of progression to these disorders

Additional Information

Activity summary
Available credit: 
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
Activity opens: 
Activity expires: 




Joseph Vassalotti, MD
Chief Medical Officer
National Kidney Foundation
Associate Clinical Professor of Medicine
Division of Nephrology
Icahn School of Medicine, Mount Sinai
New York, NY

About the presenter

Dr. Vassalotti is the Chief Medical Officer of the National Kidney Foundation (NKF) and Associate Clinical Professor of Medicine in the Division of Nephrology at the Icahn School of Medicine at Mount Sinai. He received his medical degree with Distinction in Research from the SUNY Stony Brook School of Medicine and completed an Internal Medicine Residency and Nephrology Fellowship at the Johns Hopkins Hospital. At NKF, his major focus is implementation of evidence-based clinical practice guidelines in CKD, including the NKF’s Kidney Disease Outcomes Quality Initiative (KDOQI), particularly through guidance of the NKF’s primary care initiative, called CKD intercept. He has served as co-Principal Investigator for the CDC Demonstration Project called CKD Health Evaluation and Risk Information Sharing (CHERISH), which aimed to identify individuals at high risk for CKD in the U.S. and as an investigator for the National Institutes of Health (NIH)–sponsored, clustered practice, randomized trial entitled Evidenced-based Primary Care for CKD. His leadership also includes multiple roles over the last decade with the Fistula First national quality improvement initiative for hemodialysis (sponsored by the Centers for Medicare & Medicaid Services [CMS]), including as Lead Physician Consultant from 2013 through 2015. He has served on numerous committees that shape innovation and health policy in kidney disease for the US Centers for Disease Control and Prevention (CDC), the NIH and CMS. Currently, he serves as Principal Investigator for the Kidney Score Platform, an NKF educational project funded by the Veterans Administration Center for Innovation, to improve awareness and education among veterans with and at risk for CKD in the primary care setting. Dr. Vassalotti has over 80 publications in peer-reviewed journals and has been featured in Castle Connolly’s Top Doctors and Best Doctors in America.

Activity planners
Sarah Chart, RN
Vice President
OptumHealth Education

Elizabeth Albert, MD
Clinical Activity Manager
OptumHealth Education

Disclosures of relevant financial relationships
In accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, OptumHealth Education (OHE) requires all those in control of educational content to disclose their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are defined by the ACCME as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients. Individuals must disclose all financial relationships, regardless of the amount, with ineligible companies and regardless of their view of the relevance of the relationship to the education. OHE ensures that the content is independent of commercial bias.

The activity faculty or planners have no financial relationships to disclose.

Method for calculating CE credit
CE credit was calculated by the complexity of content.

Accreditation statement
Joint Provider LogoIn support of improving patient care, this activity has been planned and implemented by OptumHealth Education and UnitedHealth Group. OptumHealth Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.

Credit designation statements
Interprofessional CEThis activity was planned by and for the health care team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credits for learning and change.

The participant will be awarded up to 1.00 contact hour(s) of credit for attendance and completion of supplemental materials.

Nurse practitioners
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts credit from organizations accredited by the ACCME and ANCC.

Pharmacists/Pharmacy technicians
This activity is approved for 1.00 contact hour ([0.10] CEU) in states that recognize ACPE.
Attending the full program will earn 1.00 contact hour.
Unique Activity Number(s): JA0007123-9999-21-301-H04-P/T

OptumHealth Education designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Academy of Physician Assistants (AAPA) accepts credit from organizations accredited by the ACCME.

OptumHealth Education is approved by the American Psychological Association (APA) to offer continuing education for psychologists. OptumHealth Education maintains responsibility for this program. 1.00 CE hour.

Social workers
ACE LogoAs a Jointly Accredited Organization, OptumHealth Education is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. OptumHealth Education maintains responsibility for this course. Social workers completing this course receive 1.00 enduring continuing education credits.

A certificate of attendance will be provided to learners upon completion of activity requirements, enabling participants to register with licensing boards or associations that have not been preapproved for credits. To apply for credit types not listed above, participants should use the procedure established by the specific organization from which they wish to obtain credit.

Available Credit

  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
Please log in to register.

You must be logged into your account to participate in this activity. Get started by clicking “Begin/Continue” and completing the “Pre-activity assessment”; then follow the prompts at the bottom of the screen. At the end of the activity, you will be able to view, save or print your certificate of participation. A complete listing of all of your activities can be found under “My Account,” “My Activities.”